To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh. ...

The stocks listed here trade at forward earnings multiples of less than 18.Valuations for many stocks are sky-high, and that can make now an unappealing time to invest in the stock market. However, there are still some great value buys that don't involve taking on a lot of risk or investing in unknown companies.Three of the best bargains you can buy today come from the healthcare sector. AstraZeneca (AZN +0.83%), CVS Health (CVS 0.13%), and Pfizer (PFE +0.04%) are all trading at incredibly low valuations wi ...

Core Viewpoint - Strategic Storage Growth Trust III, Inc. has announced the acquisition of a self-storage portfolio in Spartanburg County, South Carolina, indicating a strategic expansion in the self-storage market [1] Group 1: Acquisition Details - The acquired portfolio consists of three properties totaling approximately 179,900 net rentable square feet [1] - The portfolio includes around 1,580 storage units, with the majority being climate-controlled [1]

Core Points - Andersen Group Inc. has successfully closed its initial public offering (IPO) of 12,650,000 shares of Class A common stock [1] Company Summary - The IPO involved the issuance of 12,650,000 shares, indicating a significant step for Andersen Group Inc. in accessing public capital markets [1]

Core Insights - Kodiak Sciences Inc. successfully closed a public offering of 8,000,000 shares at a price of $23.00 per share, generating approximately $184 million in gross proceeds before expenses [1][3]. Company Overview - Kodiak Sciences is a precommercial biotechnology company focused on developing transformative therapeutics for retinal diseases, utilizing its proprietary ABC® Platform for next-generation retinal medicines [5]. Financial Position - The completion of the public offering strengthens Kodiak's financial position as it prepares for important Phase 3 topline readouts for its late-stage clinical assets: KSI-101, KSI-501, and tarcocimab [3]. Clinical Programs - Kodiak is advancing three late-stage clinical programs, with tarcocimab and KSI-501 in two BLA-facing Phase 3 studies for retinal vascular diseases, and KSI-101 being explored in two Phase 3 studies for Macular Edema Secondary to Inflammation (MESI) [5]. Underwriters - The offering was managed by J.P. Morgan, Jefferies, Evercore ISI, and UBS Investment Bank as joint book-running managers [2].

Core Viewpoint - Oil prices are experiencing downward pressure due to surplus signals and weak spot demand in the market [1] Industry Summary - The oil market is facing broader pressure from indications of surplus supply [1] - Weak demand in the spot market is contributing to the decline in oil prices [1]

Core Viewpoint - Cascade Copper Corp. has successfully closed the first tranche of a non-brokered private placement, raising a total of $600,000 (CDN) and plans to conduct a second tranche due to high demand [1]. Group 1: Offering Details - The first tranche included the issuance of 7,800,000 Critical Minerals Flow-Through units at $0.04 each and 8,000,002 Non-Flow-Through Units at $0.036 each, with each unit consisting of one common share and one-half common share purchase warrant [2]. - Each full warrant is exercisable into a common share at a price of $0.05 for a period of 36 months from the closing date of the final tranche [2]. - The offering is subject to regulatory approvals, including acceptance from the Canadian Securities Exchange, and all securities will have a four-month hold period from the closing date [3][6]. Group 2: Use of Proceeds - Proceeds from the sale of Flow-Through Shares will primarily fund eligible Critical Mineral Canadian Exploration Expenses and exploration programs in Ontario and British Columbia [5]. - Proceeds from Non-Flow-Through shares will be allocated for the general working capital of the company [5]. Group 3: Insider Participation - The offering included participation from insiders, which is classified as a related party transaction under Multilateral Instrument 61-101, with the company relying on exemptions from valuation requirements and minority approval [4]. Group 4: Company Overview - Cascade Copper is an exploration stage natural resource company focused on evaluating, acquiring, and exploring copper-based mineral resource properties, particularly in British Columbia and Ontario [8]. - The company is utilizing modern technology for exploration, including 3D inversion modeling and AI-enhanced predictive modeling, and has plans for drilling on several copper projects this year [8].

The company is capturing increasing market share from cost-conscious shoppers.There are a few reasons why folks are discussing Costco (COST 0.59%) stock, which I detail in this video.*Stock prices used were the afternoon prices of Dec. 16, 2025. The video was published on Dec. 18, 2025. ...

Group 1 - The article does not provide any specific content related to a company or industry [1]

Core Viewpoint - Annaly Capital offers a high dividend yield of 12.5%, which may attract investors, but its volatility and lack of reliability as a dividend stock warrant caution [1][6][10] Dividend Yield Analysis - Annaly Capital's yield is significantly higher than the S&P 500's 1.1%, the average financial stock's 1.3%, and the average REIT's 3.9%, being over three times larger than the average REIT and nearly ten times larger than the average finance stock [3][5] - The company's dividend has been highly volatile over time, with a trend of decreasing dividends prior to a recent increase, indicating potential risks associated with its high yield [3][6][10] Investment Strategy - While Annaly Capital may not be suitable for traditional dividend investors seeking reliability, it can still be beneficial for total return-focused investors when used as part of a diversified portfolio [9][11] - The REIT has historically provided better total returns than the S&P 500, suggesting that it can help investors build significant wealth if approached correctly [9][11] Company Characteristics - Annaly Capital operates in a unique niche within the mortgage REIT sector, requiring investors to understand its business model and the mortgage securities it purchases [10] - The company has a market capitalization of $15 billion, with a current stock price of $22.60, and has shown a trading volume of 6.1 million shares [5]